medroxyprogesterone has been researched along with Cancer of Prostate in 66 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 58 (87.88) | 18.7374 |
| 1990's | 7 (10.61) | 18.2507 |
| 2000's | 1 (1.52) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stearns, V | 1 |
| Schroeder, FH | 1 |
| Rodríguez Consoli, J; Sundblad, AS | 1 |
| De Pauw, M; Lund, F; Mulder, JH; Pavone-Macaluso, M; Smith, PH; Sylvester, R | 1 |
| Akdas, A; de Pauw, M; Mason, MK; Richards, B; Robinson, MR; Smith, PH; Sylvester, R | 1 |
| Kelly, WK; Scher, HI; Steineck, G | 1 |
| Ito, Z; Shida, K; Yamanaka, H | 1 |
| Bartsch, G; Frick, J | 1 |
| Rutten, J; Van Camp, K; van Sande, M | 1 |
| Holtzhausen, GH | 1 |
| Byar, DP; Corle, DK; Doe, RP; Seal, US | 3 |
| Blackard, CE; Seal, US; Sinha, AA | 1 |
| Declercq, G; Denis, L | 1 |
| Frick, J | 1 |
| Knowles, HC; Nolten, WE; Sholiton, LJ; Srivastava, LS; Werk, EE | 1 |
| Bouffioux, C | 1 |
| Abe, K | 1 |
| Sasagawa, I; Satomi, S | 1 |
| Bergh, A; Damber, JE; Landström, M; Tomić, R | 1 |
| Andersson, SO; Holmberg, L; Johansson, JE | 1 |
| Bezwoda, WR | 1 |
| Hagen, S; Holme, I; Klepp, O; Kloster, SE; Muri, O; Poulsen, C; Sander, S; Sivertsen, S; Tveter, KJ; Urnes, T | 1 |
| Cusan, L; Labrie, C; Labrie, F; Lapointe, S; Plante, M | 1 |
| Labrie, F; Lapointe, S; Plante, M | 1 |
| Charig, CR; Rundle, JS | 1 |
| Katayama, T; Sasagawa, I; Satomi, S | 1 |
| Ljungberg, B; Nilsson, TK; Tomic, R | 1 |
| de Pauw, M; de Voogt, HJ; Pavone-Macaluso, M; Smith, PH; Suciu, S; Sylvester, R | 1 |
| Katayama, T; Sasagawa, I; Satomi, S; Umeda, K | 1 |
| Bezwoda, WR; Derman, DP; Ruff, P; Weaving, A | 1 |
| Barasolo, E; de Pauw, M; de Voogt, HJ; Lardennois, B; Pavone-Macaluso, M; Schröder, FH; Smith, PH; Suciu, S; Sylvester, R; Viggiano, G | 1 |
| de Pauw, M; de Voogt, HJ; Pavone-Macaluso, M; Smith, PH; Suciu, S | 2 |
| Decensi, A; Pavesi, L; Prada, GA; Preti, P; Robustelli della Cuna, G; Zanon, P | 1 |
| Barasolo, E; de Pauw, M; de Voogt, HJ; Lardennois, B; Pavone-Macaluso, M; Sylvester, R; Viggiano, G | 1 |
| Fair, WR | 1 |
| Bensimon, H; Bunn, PA; Cohen, MH; Dunnick, NR; Eddy, JL; Ihde, DC; Javadpour, N; Makuch, RW; Minna, JD; Seifter, EJ | 1 |
| Damber, JE; Landström, M; Tomić, R | 1 |
| Barasolo, E; De Pauw, M; de Voogt, H; Ingargiola, GB; Lardennois, B; Pavone-Macaluso, M; Sylvester, R; Viggiano, G | 1 |
| Matsumoto, K; Noguchi, S | 1 |
| Flamm, J; Spona, J | 2 |
| Damber, JE; Ljungberg, B; Tomić, R | 2 |
| Debruyne, FM | 1 |
| Robinson, MR | 1 |
| deVoogt, HJ; Pavone-Macaluso, M; Schröder, FH; Sylvester, R | 1 |
| Gröhn, P; Kontturi, M; Lukkarinen, O; Romppainen, ML; Sotarauta, M; Tammela, T | 1 |
| Bollack, C; Rougeron, G | 1 |
| Fosså, SD; Haveland, H; Jahnsen, JU; Karlsen, S; Ogreid, P; Trovåg, A | 1 |
| Johansson, JE; Lingårdh, G | 1 |
| Fujita, Y; Kamei, Y; Kohama, Y; Morioka, M; Sen, Y; Sonobe, H; Yamamoto, Y | 1 |
| Fosså, SD; Urnes, T | 1 |
| Boublil, JL; Cavaglione, G; Kather, R; Namer, M | 1 |
| de Voogt, H; Macaluso, MP; Robinson, MR; Smith, PH; Sylvester, R | 1 |
| Popelier, G | 1 |
| Johnson, R; Rafla, S | 1 |
| Kontturi, M; Sotaniemi, E | 1 |
| Blackard, CE; Dixon, R; Giebenhain, M; Gurpide, E; Notation, A; Stolee, A | 1 |
| Furnari, S; Mattea, E; Pavone-Macaluso, M; Veroux, G | 1 |
| Clavel, B | 1 |
| Blackard, CE; Byar, DP; Doe, RP; Seal, US | 1 |
| Milano, S; Pagliari, G; Ronzoni, G; Wiel Marin, A | 1 |
| Helmreich, ML; Huseby, RA | 1 |
8 review(s) available for medroxyprogesterone and Cancer of Prostate
| Article | Year |
|---|---|
Management of hot flashes in breast cancer survivors and men with prostate cancer.
Topics: Amines; Anti-Anxiety Agents; Breast Neoplasms; Complementary Therapies; Contraceptives, Oral, Synthetic; Cyclohexanecarboxylic Acids; Cyclohexanols; Drug Therapy, Combination; Estrogen Replacement Therapy; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Male; Medroxyprogesterone; Menopause, Premature; Paroxetine; Prostatic Neoplasms; Quality of Life; Selective Serotonin Reuptake Inhibitors; Survivors; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
Hormone therapy in prostatic cancer.
Topics: Cyproterone; Diethylstilbestrol; Estrogens; Humans; Male; Medroxyprogesterone; Prostatic Neoplasms | 1980 |
Hormone-refractory (D3) prostate cancer: refining the concept.
Topics: Aminoglutethimide; Clinical Trials as Topic; Cortisone; Dexamethasone; Drug Therapy, Combination; Humans; Hydrocortisone; Male; Medroxyprogesterone; Mitoxantrone; Neoplasm Recurrence, Local; Prednisone; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Suramin; Treatment Outcome | 1995 |
[Clinical aspects of the anti-androgens].
Topics: 17-Ketosteroids; Acne Vulgaris; Adrenal Hyperplasia, Congenital; Androgen Antagonists; Androgens; Androsterone; Contraceptives, Oral, Hormonal; Cyclopentanes; Cyproterone; Dermatitis, Seborrheic; Dihydrotestosterone; Estradiol Congeners; Female; Follicle Stimulating Hormone; Glucocorticoids; Hirsutism; Humans; Hydroxysteroids; Luteinizing Hormone; Male; Medroxyprogesterone; Nandrolone; Prostatic Neoplasms; Receptors, Androgen; Sex Hormone-Binding Globulin; Steroids; Testosterone | 1979 |
[Hormone therapy of neoplasms].
Topics: Adenoma, Islet Cell; Aminoglutethimide; Breast Neoplasms; Female; Fluoxymesterone; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Pancreatic Neoplasms; Prostatic Neoplasms; Tamoxifen | 1991 |
An overview of clinical trials with high-dose medroxyprogesterone acetate (HD-MPA) in endocrine-related tumors other than breast cancer.
Topics: Administration, Oral; Carcinoma, Renal Cell; Clinical Trials as Topic; Diethylstilbestrol; Female; Humans; Injections, Intramuscular; Kidney Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Ovarian Neoplasms; Prostatic Neoplasms; Uterine Neoplasms | 1986 |
Is there a best endocrine management of prostatic carcinoma?
Topics: Antineoplastic Combined Chemotherapy Protocols; Castration; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Estramustine; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Prostatic Neoplasms | 1988 |
[Medical treatment of malignant bone tumors (carcinolytics, hormonotherapy, immunotherapy)].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Doxorubicin; Hormones; Humans; Immunity, Cellular; Immunotherapy; Kidney Neoplasms; Leukemia; Lung Neoplasms; Lymphoma; Male; Medroxyprogesterone; Methods; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prognosis; Prostatic Neoplasms; Testosterone; Thyroid Neoplasms; Viral Interference | 1974 |
22 trial(s) available for medroxyprogesterone and Cancer of Prostate
| Article | Year |
|---|---|
Treatment of prostatic cancer: the EORTC experience--preliminary results of prostatic carcinoma trials.
Topics: Castration; Clinical Trials as Topic; Combined Modality Therapy; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Doxorubicin; Estramustine; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Mitomycin; Mitomycins; Procarbazine; Prostatic Neoplasms; Random Allocation; Vinblastine; Vindesine | 1984 |
EORTC protocols in prostatic cancer. An interim report.
Topics: Cyproterone; Diethylstilbestrol; Doxorubicin; Estramustine; Humans; Male; Medroxyprogesterone; Prostatic Neoplasms | 1980 |
Response of serum cholesterol and triglycerides to hormone treatment and the relation of pretreatment values to mortality in patients with prostatic cancer.
Topics: Cholesterol; Diethylstilbestrol; Dose-Response Relationship, Drug; Drug Therapy, Combination; Estrogens; Estrogens, Conjugated (USP); Humans; Male; Medroxyprogesterone; Prostatic Neoplasms; Triglycerides | 1976 |
Response of plasma fibrinogen and plasminogen to hormone treatment and the relation of pretreatment values to mortality in patients with prostatic cancer.
Topics: Age Factors; Body Weight; Clinical Trials as Topic; Diethylstilbestrol; Dose-Response Relationship, Drug; Estrogens, Conjugated (USP); Fibrinogen; Humans; Male; Medroxyprogesterone; Plasminogen; Prostatic Neoplasms | 1976 |
High-dose medroxyprogesterone acetate versus estramustine in therapy-resistant prostatic cancer: a randomised study.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Bone Neoplasms; Delayed-Action Preparations; Estramustine; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Prognosis; Prostatic Neoplasms; Time Factors | 1991 |
Treatment of stage D2 prostatic cancer refractory to or relapsed following castration plus oestrogens. Comparison of aminoglutethimide plus hydrocortisone with medroxyprogesterone acetate plus hydrocortisone.
Topics: Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Diethylstilbestrol; Humans; Hydrocortisone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Staging; Orchiectomy; Postoperative Period; Prostatic Neoplasms; Randomized Controlled Trials as Topic | 1990 |
A randomized study on hormone-resistant prostatic cancer: estramustine phosphate versus low dose epirubicin with or without medroxyprogesterone acetate. A Norwegian multicenter study.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Agents; Drug Therapy, Combination; Epirubicin; Estramustine; Humans; Injections, Intravenous; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Norway; Placebos; Prospective Studies; Prostatic Neoplasms; Remission Induction | 1990 |
Multivariate analysis of prognostic factors in patients with advanced prostatic cancer: results from 2 European Organization for Research on Treatment of Cancer trials.
Topics: Adult; Aged; Aged, 80 and over; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Estramustine; Europe; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Multicenter Studies as Topic; Nitrogen Mustard Compounds; Prognosis; Prospective Studies; Prostatic Neoplasms; Random Allocation; Statistics as Topic | 1989 |
Sequential hormonal therapy and sequential hormonal and chemotherapy for advanced prostatic cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Combined Modality Therapy; Diethylstilbestrol; Drug Administration Schedule; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Orchiectomy; Prostatic Neoplasms; Time Factors | 1989 |
EORTC protocol 30761: a randomized study of non-metastatic and metastatic prostatic cancer treated by cyproterone acetate versus diethylstilbestrol and medroxyprogesterone acetate. European Organization for Research on Treatment of Cancer Urological Group
Topics: Androgen Antagonists; Antineoplastic Agents; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Europe; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Multicenter Studies as Topic; Prostatic Neoplasms; Random Allocation | 1989 |
Cardiovascular side effects of diethylstilbestrol, cyproterone acetate, medroxyprogesterone acetate and estramustine phosphate used for the treatment of advanced prostatic cancer: results from European Organization for Research on Treatment of Cancer tria
Topics: Aged; Body Weight; Cardiovascular Diseases; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Estramustine; Europe; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Nitrogen Mustard Compounds; Prostatic Neoplasms; Random Allocation; Time Factors | 1986 |
An overview of clinical trials with high-dose medroxyprogesterone acetate (HD-MPA) in endocrine-related tumors other than breast cancer.
Topics: Administration, Oral; Carcinoma, Renal Cell; Clinical Trials as Topic; Diethylstilbestrol; Female; Humans; Injections, Intramuscular; Kidney Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Ovarian Neoplasms; Prostatic Neoplasms; Uterine Neoplasms | 1986 |
Comparison of diethylstilbestrol, cyproterone acetate and medroxyprogesterone acetate in the treatment of advanced prostatic cancer: final analysis of a randomized phase III trial of the European Organization for Research on Treatment of Cancer Urological
Topics: Aged; Bone Neoplasms; Carcinoma; Cardiovascular Diseases; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Europe; Follow-Up Studies; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Prostatic Neoplasms; Random Allocation | 1986 |
A trial of combination chemotherapy followed by hormonal therapy for previously untreated metastatic carcinoma of the prostate.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Diethylstilbestrol; Doxorubicin; Drug Therapy, Combination; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Orchiectomy; Pilot Projects; Prostatic Neoplasms | 1986 |
Cyproterone acetate versus medroxyprogesterone acetate versus diethylstilbestrol in the treatment of prostate cancer: results from EORTC Study 30761.
Topics: Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Prostatic Neoplasms | 1987 |
Lessons from phase III-trials on the hormonal treatment of prostatic cancer. I: Results of EORTC-trials 30761 and 30762.
Topics: Antineoplastic Agents; Carcinoma; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Drug Administration Schedule; Estramustine; Europe; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Prostatic Neoplasms; Random Allocation | 1988 |
Results of a Dutch trial with the LHRH agonist buserelin in patients with metastatic prostatic cancer and results of EORTC studies in prostatic cancer.
Topics: Aged; Buserelin; Clinical Trials as Topic; Combined Modality Therapy; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Humans; Lymphatic Metastasis; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Netherlands; Orchiectomy; Prostatic Neoplasms; Remission Induction; Time Factors | 1988 |
Is there a best endocrine management of prostatic carcinoma?
Topics: Antineoplastic Combined Chemotherapy Protocols; Castration; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Estramustine; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Prostatic Neoplasms | 1988 |
Re: Cardiovascular side effects of diethylstilbestrol, cyproterone acetate, medroxyprogesterone acetate and estramustine phosphate used for the treatment of advanced prostatic cancer: results from European Organization for Research on Treatment of Cancer
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Estramustine; Heart; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Prostatic Neoplasms | 1988 |
The EORTC Phase III trials in prostatic cancer.
Topics: Castration; Clinical Trials as Topic; Cyproterone; Diethylstilbestrol; Estramustine; Humans; Male; Medroxyprogesterone; Neoplasm Metastasis; Nitrogen Mustard Compounds; Prostatic Neoplasms; Random Allocation | 1985 |
The treatment of advanced prostatic carcinoma with medroxyprogesterone.
Topics: Acid Phosphatase; Adult; Aged; Alkaline Phosphatase; Calcium; Clinical Trials as Topic; Humans; Male; Medroxyprogesterone; Middle Aged; Neoplasm Metastasis; Prostatic Neoplasms; Time Factors | 1974 |
Correlation of pretreatment serum nonprotein-bound cortisol and total 17-hydroxycorticosteroid values with survival in patients with prostatic cancer.
Topics: 17-Hydroxycorticosteroids; Aged; Binding, Competitive; Clinical Trials as Topic; Diethylstilbestrol; Estrogens, Conjugated (USP); Fluorometry; Humans; Hydrocortisone; Male; Medroxyprogesterone; Placebos; Prognosis; Prostatectomy; Prostatic Neoplasms; Protein Binding | 1974 |
38 other study(ies) available for medroxyprogesterone and Cancer of Prostate
| Article | Year |
|---|---|
[Carcinoma of the prostatic utricle treated with medroxyprogesterone].
Topics: Aged; Carcinoma; Humans; Male; Medroxyprogesterone; Prostatic Neoplasms | 1984 |
[Androgens].
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androgen Antagonists; Androgen-Insensitivity Syndrome; Androgens; Animals; Dihydrotestosterone; Female; Male; Medroxyprogesterone; Prostatic Hyperplasia; Prostatic Neoplasms; Rats; Receptors, Cell Surface; Testosterone | 1975 |
Hormonal status in prostatic disease.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Age Factors; Aged; Androstenediols; Castration; Child; Chorionic Gonadotropin; Dihydrotestosterone; Estradiol; Female; Follicle Stimulating Hormone; Hormones; Humans; Luteinizing Hormone; Male; Medroxyprogesterone; Middle Aged; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone | 1976 |
[Preliminary report on the effect of medroxyprogesterone acetate on human prostate LDH-isoenzymes].
Topics: Humans; Isoenzymes; L-Lactate Dehydrogenase; Male; Medroxyprogesterone; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms | 1977 |
A critical analysis of tumor morphology and hormone treatments in the untreated and estrogen-treated responsive and refractory human prostatic carcinoma.
Topics: Adenocarcinoma; Diethylstilbestrol; Drug Resistance; Drug Therapy, Combination; Endocrine Glands; Estrogens; Estrogens, Conjugated (USP); Humans; Luteinizing Hormone; Male; Medroxyprogesterone; Prostatic Neoplasms; Testosterone | 1977 |
Response of serum haptoglobin to hormone treatment and the relation of pretreatment values to mortality in patients with prostatic cancer.
Topics: Aged; Diethylstilbestrol; Dose-Response Relationship, Drug; Estrogens; Estrogens, Conjugated (USP); Fibrinogen; Haptoglobins; Humans; Hydrocortisone; Male; Medroxyprogesterone; Middle Aged; Neoplasm Metastasis; Prognosis; Prostatic Neoplasms; Time Factors | 1978 |
Progestogens in prostatic cancer.
Topics: Acid Phosphatase; Adenocarcinoma; Aged; Dose-Response Relationship, Drug; Gonadotropins, Pituitary; Humans; Male; Medroxyprogesterone; Middle Aged; Prostatic Neoplasms; Testosterone | 1978 |
[Surgical and hormonal therapy of prostatic carcinoma].
Topics: Aged; Antineoplastic Agents; Cryosurgery; Estrogens; Ethinyl Estradiol; Humans; Male; Medroxyprogesterone; Prostatic Neoplasms | 1977 |
The effects of diethylstilbestrol and medroxyprogesterone acetate on kinetics and production of testosterone and dihydrotestosterone in patients with prostatic carcinoma.
Topics: Aged; Diethylstilbestrol; Dihydrotestosterone; Humans; Kinetics; Male; Medroxyprogesterone; Metabolic Clearance Rate; Middle Aged; Prostatic Neoplasms; Testosterone | 1976 |
[Treatment of prostatic cancer with progestational agents].
Topics: Aged; Drug Evaluation; Humans; Male; Medroxyprogesterone; Middle Aged; Neoplasm Metastasis; Prostatic Neoplasms | 1976 |
Effect of high-dose medroxyprogesterone acetate on plasma hormone levels and pain relief in patients with advanced prostatic cancer.
Topics: Adrenocorticotropic Hormone; Aged; Antineoplastic Agents; Bone Neoplasms; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Follicle Stimulating Hormone; Gonadotropins; Growth Hormone; Humans; Hydrocortisone; Luteinizing Hormone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Palliative Care; Prolactin; Prostatic Neoplasms; Thyrotropin | 1990 |
Treatment of rat prostatic adenocarcinoma with medroxyprogesterone acetate (MPA): effects on growth and morphology.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Castration; Estradiol; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Prostatic Neoplasms; Rats; Rats, Inbred F344; Testosterone | 1991 |
Analysis of the androgenic activity of synthetic "progestins" currently used for the treatment of prostate cancer.
Topics: Adrenal Glands; Animals; Chlormadinone Acetate; Cyproterone; Cyproterone Acetate; Dihydrotestosterone; Flutamide; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Organ Size; Ornithine Decarboxylase; Progesterone Congeners; Prostate; Prostatic Neoplasms; Rats; Rats, Inbred Strains; Spironolactone | 1987 |
Stimulatory effect of synthetic progestins currently used for the treatment of prostate cancer on growth of the androgen-sensitive Shionogi tumor in mice.
Topics: Androgens; Animals; Chlormadinone Acetate; Cyproterone; Cyproterone Acetate; Female; Flutamide; Male; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Mice; Progesterone Congeners; Prostatic Neoplasms | 1988 |
Flushing. Long-term side effect of orchiectomy in treatment of prostatic carcinoma.
Topics: Aged; Aged, 80 and over; Flushing; Follicle Stimulating Hormone; Humans; Hydroxyindoleacetic Acid; Luteinizing Hormone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Orchiectomy; Pilot Projects; Prolactin; Prostatic Neoplasms; Vanilmandelic Acid | 1989 |
[Remarkable pain relief in the treatment with high-dose medroxyprogesterone acetate in advanced prostatic carcinoma].
Topics: Adrenocorticotropic Hormone; Back Pain; Bone and Bones; Bone Neoplasms; Chlormadinone Acetate; Dehydroepiandrosterone; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Pain, Intractable; Palliative Care; Prostatic Neoplasms; Radionuclide Imaging | 1989 |
Effects of high dose medroxyprogesterone acetate treatment on antithrombin III and other plasma proteins in males with renal cell or prostatic carcinoma.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Antithrombin III; Blood Proteins; Carcinoma, Renal Cell; Delayed-Action Preparations; Haptoglobins; Humans; Kidney Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Prostatic Neoplasms | 1989 |
[Pain relief by high-dose medroxyprogesterone acetate in advanced prostatic cancer].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Agents; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Pain, Intractable; Prostatic Neoplasms | 1989 |
Hormonal therapy of advanced prostatic cancer.
Topics: Antineoplastic Agents; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Estramustine; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Prostatic Neoplasms | 1986 |
Effect of medroxyprogesterone acetate, alone or in combination with epirubicin hydrochloride, on the growth of the Dunning R3327H prostatic adenocarcinoma.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line; Doxorubicin; Epirubicin; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Transplantation; Orchiectomy; Prostatic Neoplasms; Rats; Testosterone | 1987 |
[Hormone therapy--recent advances].
Topics: Breast Neoplasms; Female; Gonadotropin-Releasing Hormone; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Receptors, Androgen; Receptors, Estrogen; Tamoxifen; Uterine Neoplasms | 1987 |
[High-dosage medroxyprogesterone acetate treatment in advanced prostatic cancer].
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Combined Modality Therapy; Dose-Response Relationship, Drug; Humans; Luteinizing Hormone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Prostatic Neoplasms; Testosterone | 1987 |
The influence of medroxyprogesterone acetate (MPA) on hormone parameters in prostatic carcinoma patients.
Topics: Aged; Aged, 80 and over; Carcinoma; Dose-Response Relationship, Drug; Humans; Luteinizing Hormone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Orchiectomy; Prostatic Neoplasms; Testosterone | 1988 |
Hormonal effects of high dose medroxyprogesterone acetate treatment in males with renal or prostatic adenocarcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Dehydroepiandrosterone; Estradiol; Follicle Stimulating Hormone; Hormones; Humans; Hydrocortisone; Kidney Neoplasms; Luteinizing Hormone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Prolactin; Prostatic Neoplasms; Serum Albumin; Sex Hormone-Binding Globulin; Testosterone | 1988 |
Endocrinological effects of treatment with high doses of medroxyprogesterone acetate in patients with renal or prostatic adenocarcinoma.
Topics: Adenocarcinoma; Androgens; Antineoplastic Agents; Carcinoma, Renal Cell; Humans; Kidney Neoplasms; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Prostatic Neoplasms; Sex Hormone-Binding Globulin | 1988 |
Sequentially alternating hormone chemotherapy with high-dose medroxy-progesterone acetate and low-dose epirubicin for the treatment of hormone-resistant metastatic prostatic cancer.
Topics: Actuarial Analysis; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Delayed-Action Preparations; Drug Administration Schedule; Drug Evaluation; Epirubicin; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Prostatic Neoplasms | 1988 |
Hormonal therapy trials in prostatic cancer. An EORTC Genitourinary Group study.
Topics: Androgen Antagonists; Carcinoma; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Estramustine; Europe; Gonadotropin-Releasing Hormone; Hormones; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Orchiectomy; Prostatic Neoplasms | 1988 |
High-dose medroxyprogesterone acetate versus prednisolone in hormone-resistant prostatic cancer. A pilot study.
Topics: Acid Phosphatase; Aged; Antineoplastic Agents; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Pilot Projects; Prednisolone; Prostatic Neoplasms; Random Allocation; Time Factors | 1985 |
High-dose medroxyprogesterone in the treatment of advanced therapy-resistant prostatic carcinoma.
Topics: Aged; Antineoplastic Agents; Carcinoma; Combined Modality Therapy; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Prostatic Neoplasms | 1985 |
[Prognostic evaluation of prostatic cancer by Gleason's histopathologic grading and tissue DHT level].
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Diethylstilbestrol; Dihydrotestosterone; Humans; Male; Medroxyprogesterone; Middle Aged; Neoplasm Staging; Prognosis; Prostatic Neoplasms | 1988 |
Flare reaction during the initial treatment period with medroxyprogesterone acetate in patients with hormone-resistant prostatic cancer.
Topics: Aged; Drug Resistance; Hormones; Humans; Male; Medroxyprogesterone; Middle Aged; Orchiectomy; Pain; Prostatic Neoplasms | 1986 |
[Cancer of the prostate: new hormone therapies].
Topics: Androgen Antagonists; Cyproterone; Flutamide; Humans; Ketoconazole; Male; Medroxyprogesterone; Megestrol; Neoplasms, Hormone-Dependent; Progestins; Prostatic Neoplasms; Tamoxifen | 1986 |
[Treatment of the carcinoma of the prostate with gestagens (author's transl)].
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Carcinoma; Chlormadinone Acetate; Estrogens; Evaluation Studies as Topic; Humans; Male; Medroxyprogesterone; Megestrol; Progesterone; Prostatic Neoplasms | 1973 |
Thromboembolism during estrogen therapy of prostatic cancer. Report on two cases.
Topics: Adenosine Triphosphatases; Adult; Age Factors; Aged; Anticholesteremic Agents; Anticoagulants; Blood Coagulation Factors; Blood Glucose; Blood Platelets; Carcinoma; Cardiovascular System; Castration; Contraceptives, Oral; Estrogens; Female; Glucose Tolerance Test; Humans; Hypercholesterolemia; Leg; Lipids; Liver; Male; Medroxyprogesterone; Middle Aged; Myocardial Infarction; Phlebography; Phosphatidylcholines; Prostatic Neoplasms; Thromboembolism; Thrombophlebitis | 1971 |
Stimulation of 16alpha-hydroxylation of dehydroisoandrosterone sulfate by diethylstilbestrol.
Topics: Aged; Carbon Radioisotopes; Dehydroepiandrosterone; Diethylstilbestrol; Humans; Hydroxylation; Male; Medroxyprogesterone; Middle Aged; Prostatic Neoplasms; Sulfates; Tritium | 1973 |
Cancer chemotherapy in urology.
Topics: Adenocarcinoma; Alkylating Agents; Antibiotics, Antineoplastic; Antimetabolites; Chlorambucil; Cobalt; Dactinomycin; Dysgerminoma; Female; Fluorouracil; Humans; Kidney Neoplasms; Male; Medroxyprogesterone; Neoplasm Metastasis; Neoplasm Recurrence, Local; Papilloma; Prostatic Neoplasms; Teratoma; Testicular Neoplasms; Testosterone; Thiotepa; Urinary Bladder Neoplasms; Urogenital Neoplasms; Vincristine; Wilms Tumor | 1971 |
[Effect of prolonged high dose administration of an anti-androgen (medroxyprogesterone acetate) on testicular function in rats].
Topics: Androgen Antagonists; Animals; Male; Medroxyprogesterone; Organ Size; Prostatic Neoplasms; Rats; Spermatozoa; Testis; Time Factors | 1969 |
Factors influencing the absorption of medroxyprogesterone acetate.
Topics: Breast Neoplasms; Female; Humans; Injections, Intramuscular; Intestinal Absorption; Male; Medroxyprogesterone; Prostatic Neoplasms; Tablets; Urine | 1965 |